XML 102 R6.htm IDEA: XBRL DOCUMENT v3.20.1
Consolidated Statements of Changes in Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Treasury Stock
Accumulated Other Comprehensive Loss
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2018   143,444,178   0    
Beginning balance at Dec. 31, 2018 $ 174,454 $ 14 $ 961,235 $ 0 $ (3,211) $ (783,584)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Vesting of restricted shares (in shares)   116,526        
Vesting of restricted shares 0          
Exercise of stock options (in shares)   892        
Exercise of stock options 5   5      
Other comprehensive gain (loss) (1,362)       (1,362)  
Net loss (3,488)         (3,488)
Stock-based compensation 9,016   9,016      
Ending balance (in shares) at Mar. 31, 2019   143,561,596   0    
Ending balance at Mar. 31, 2019 178,625 $ 14 970,256 $ 0 (4,573) (787,072)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Vesting of restricted shares (in shares)   2,176,738        
Vesting of restricted shares 0          
Exercise of stock options (in shares)   2,918        
Exercise of stock options 16   16      
Other comprehensive gain (loss) 458       458  
Net loss (26,228)         (26,228)
Stock-based compensation 9,354   9,354      
Ending balance (in shares) at Jun. 30, 2019   145,741,252   0    
Ending balance at Jun. 30, 2019 162,225 $ 14 979,626 $ 0 (4,115) (813,300)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Vesting of restricted shares (in shares)   398,293        
Vesting of restricted shares 0 $ 1 (1)      
Exercise of stock options (in shares)   1,331        
Exercise of stock options 5   5      
Other comprehensive gain (loss) (761)       (761)  
Net loss 7,816         7,816
Stock-based compensation 9,143   9,143      
Ending balance (in shares) at Sep. 30, 2019   146,140,876   0    
Ending balance at Sep. 30, 2019 178,428 $ 15 988,773 $ 0 (4,876) (805,484)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Vesting of restricted shares (in shares)   117,340        
Vesting of restricted shares 0          
Exercise of stock options (in shares)   1,652        
Exercise of stock options 6   6      
Other comprehensive gain (loss) 788       788  
Net loss 9,553         9,553
Stock-based compensation 8,179   8,179      
Ending balance (in shares) at Dec. 31, 2019   146,259,868   0    
Ending balance at Dec. 31, 2019 196,954 $ 15 996,958 $ 0 (4,088) (795,931)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Vesting of restricted shares (in shares)   1,306,607        
Vesting of restricted shares 0          
Exercise of stock options (in shares)   3,597        
Exercise of stock options 13   13      
Other comprehensive gain (loss) (185)       (185)  
Net loss (2,244)         (2,244)
Stock-based compensation 9,836   9,836      
Repurchase of common stock (in shares)       (7,603,620)    
Repurchase of common stock (12,329)     $ (12,329)    
Ending balance (in shares) at Mar. 31, 2020   147,570,072   (7,603,620)    
Ending balance at Mar. 31, 2020 $ 192,045 $ 15 $ 1,006,807 $ (12,329) $ (4,273) $ (798,175)